Navigation Links
Oncologists Overlook Clot Risk

Cancer patients who receive treatment have a greater risk of developing blood clots, but a new study shows many doctors are not taking the necessary steps to prevent the clots from forming.//

Researchers in England, surveyed more than 100 oncologists to determine if the doctors were aware of the risk of blood clots and to evaluate preventative measures used by the physicians. About 40 percent of the doctors who were surveyed treated their patients with either chemotherapy or radiotherapy, and less than 10 percent said they used hormone therapy on their patients.

Results of the study show more than 90 of the 160 doctors surveyed thought radiotherapy posed little or no increased risk for blood clots. More than 80 doctors thought the same for chemotherapy, and more than 70 agreed hormone therapy did not increase the risk.

Of the doctors surveyed, 84 did not routinely recommend blood thinners, such as aspirin or warfarin, as a preventative measure for patients treated with chemotherapy. Seventy-nine doctors did not recommend the medication for hormone therapy patients, and 86 did not advise radiotherapy patients to use the blood thinners. Nearly 40 percent of the oncologists said less than 1 percent of their patients were currently using prophylactic measures for preventing blood clots.

Researchers say health care professionals need to be better educated about the potential increased risk of blood clots in cancer patients.

Thus researchers conclude, “National guidelines on prophylaxis for venous thromboembolism during cancer treatment are needed.”


'"/>




Page: 1

Related medicine news :

1. Dental Health, a Much Overlooked Subject
2. Was the Warning of a Severe Reaction To a Drug, Overlooked?
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... Pastor and Overseer at The House of Yahweh in Abilene, Texas, has published a new ... not. Yisrayl says with so many titles and names for the Creator, it’s hard ... a little Scripture, backed with a lot of research, the truth is undeniable. , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Woolsy Corporation Limited, a ... its Nova Skin Sciences division, recently announced the launch of Allumière Antiaging Cream, ... power of an anti-aging concentrate. , Anogeissus Leiocarpa Bark Extract and ...
(Date:4/28/2017)... Tenn. (PRWEB) , ... April 28, 2017 , ... ... system, today announced an alliance with B. Braun Medical Inc. , a leader ... role in patient care with as many as 90 percent of hospital patients receiving ...
(Date:4/27/2017)... , ... April 27, 2017 , ... ... natural deodorant. On the heels of Thinksport’s award-winning sunscreen they’ve used the same ... that actually works! , Countless deodorants flood the aisles that contain harmful chemicals ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced ... Lincoln, Neb. area this year. , The first new location will open at ... will open at 84th and Northern Lights Drive this fall. And the third location ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... NEW YORK , April 19, 2017 /PRNewswire/ ... This report on the prostate cancer ... of the global market. Increasing prevalence of prostate ... as innovation in the development of new drugs ... hormone-refractory prostate cancer drug due to lesser side ...
(Date:4/19/2017)... April 19, 2017  Sorrento Therapeutics, Inc. (NASDAQ: ... biopharmaceutical company developing new treatments for cancer and ... of its previously announced underwritten public offering of ... public offering price of $2.00 per share, before ... expenses payable by Sorrento.  The net proceeds to ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology: